1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Nuclear Medicine Global Market Analysis – Forecast (2014-2020)

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.

This report analyzes the global markets for “Nuclear Medicine“. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities.

This report provides:
- Market forecasts for a minimum of 5 years of all the mentioned segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Market share assessments of the top players along with strategic recommendations for the new entrants

Table Of Contents

Nuclear Medicine Global Market Analysis - Forecast (2014-2020)
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Nuclear Medicine Global Market, by Isotope
5.1 Diagnostics
5.1.1 SPECT
5.1.1.1 Iodine (I-123)
5.1.1.2 Gallium (Ga-67)
5.1.1.3 Thallium (Tl-201)
5.1.1.4 Technetium (Tc-99m)
5.1.1.5 Rhenium (Re-186)
5.1.1.6 Yttrium (Y-90)
5.1.1.7 Others
5.1.2 PET
5.1.2.1 Fludeoxyglucose (18f-FDG)
5.1.2.2 Rubidium (Rb-82)
5.1.2.3 Others
5.2 Therapy
5.2.1 Beta radiation therapy
5.2.1.1 Erbium (Er-169)
5.2.1.2 Iodine (I-131)
5.2.1.3 Lutetium (Lu-177)
5.2.1.4 Rhenium (Re-186)
5.2.1.5 Samarium (Sm-153)
5.2.1.6 Strontium (Sr-89)
5.2.1.7 Yttrium (Y-90)
5.2.1.8 Others
5.2.2 Alpha radiation therapy
5.2.2.1 Actinium (Ac-225)
5.2.2.2 Astatine-211 (At-211)
5.2.2.3 Lead (Pb-212)/Bismuth (Bi-212)
5.2.2.4 Radium (Ra-223)
5.2.2.5 Radium-224 (Ra-224)
5.2.2.6 Thorium-227 (Th-227)
5.2.2.7 Others
5.2.3 Brachytherapy
5.2.3.1 Cesium (Cs-131)
5.2.3.2 Iodine (I-125)
5.2.3.3 Iridium (Ir-192)
5.2.3.4 Palladium (Pd-103)
5.2.3.5 Others

6 Nuclear Medicine Global Market, by End-User
6.1 Introduction
6.2 Hospitals
6.3 Diagnostic centers

7 Geographical Segmentation
7.1 North America
7.1.1 US
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 Newzealand
7.3.6 Rest of Asia Pacific
7.4 RoW
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
7.4.4 Others

8 Vendor Landscaping
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions and Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiles
9.1 Mallinckrodt Plc
9.1.1 Business Overview
9.1.2 SWOT Analysis
9.1.3 Financial Overview
9.1.4 Strategy
9.1.5 Key Activities
9.2 Nordion Inc
9.3 IBA Group
9.4 Cardinal Health Inc
9.5 GE Healthcare
9.6 Lantheus Medical Imaging Inc

10 Appendix
11 Disclaimer

List of Exhibits
Table 1 Global Nuclear Medicine Market Analysis, by Isotope, 2013-2020 ($MN)
Table 2 Global Nuclear Medicine Market Analysis, by Diagnostics, 2013-2020 ($MN)
Table 3 Global Nuclear Medicine Market Analysis, by SPECT, 2013-2020 ($MN)
Table 4 Global Nuclear Medicine Market Analysis, by Iodine (I-123), 2013-2020 ($MN)
Table 5 Global Nuclear Medicine Market Analysis, by Gallium (Ga-67), 2013-2020 ($MN)
Table 6 Global Nuclear Medicine Market Analysis, by Thallium (Tl-201), 2013-2020 ($MN)
Table 7 Global Nuclear Medicine Market Analysis, by Technetium (Tc-99m), 2013-2020 ($MN)
Table 8 Global Nuclear Medicine Market Analysis, by Rhenium (Re-186), 2013-2020 ($MN)
Table 9 Global Nuclear Medicine Market Analysis, by Yttrium (Y-90), 2013-2020 ($MN)
Table 10 Global Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 11 Global Nuclear Medicine Market Analysis, by PET, 2013-2020 ($MN)
Table 12 Global Nuclear Medicine Market Analysis, by Fludeoxyglucose (18f-FDG), 2013-2020 ($MN)
Table 13 Global Nuclear Medicine Market Analysis, by Rubidium (Rb-82), 2013-2020 ($MN)
Table 14 Global Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 15 Global Nuclear Medicine Market Analysis, by Therapy, 2013-2020 ($MN)
Table 16 Global Nuclear Medicine Market Analysis, by Beta radiation therapy, 2013-2020 ($MN)
Table 17 Global Nuclear Medicine Market Analysis, by Erbium (Er-169), 2013-2020 ($MN)
Table 18 Global Nuclear Medicine Market Analysis, by Iodine (I-131), 2013-2020 ($MN)
Table 19 Global Nuclear Medicine Market Analysis, by Lutetium (Lu-177), 2013-2020 ($MN)
Table 20 Global Nuclear Medicine Market Analysis, by Rhenium (Re-186), 2013-2020 ($MN)
Table 21 Global Nuclear Medicine Market Analysis, by Samarium (Sm-153), 2013-2020 ($MN)
Table 22 Global Nuclear Medicine Market Analysis, by Strontium (Sr-89), 2013-2020 ($MN)
Table 23 Global Nuclear Medicine Market Analysis, by Yttrium (Y-90), 2013-2020 ($MN)
Table 24 Global Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 25 Global Nuclear Medicine Market Analysis, by Alpha radiation therapy, 2013-2020 ($MN)
Table 26 Global Nuclear Medicine Market Analysis, by Actinium (Ac-225), 2013-2020 ($MN)
Table 27 Global Nuclear Medicine Market Analysis, by Actinium (Ac-225), 2013-2020 ($MN)
Table 28 Global Nuclear Medicine Market Analysis, by Astatine-211 (At-211), 2013-2020 ($MN)
Table 29 Global Nuclear Medicine Market Analysis, by Lead (Pb-212)/Bismuth (Bi-212), 2013-2020 ($MN)
Table 30 Global Nuclear Medicine Market Analysis, by Radium (Ra-223), 2013-2020 ($MN)
Table 31 Global Nuclear Medicine Market Analysis, by Radium-224 (Ra-224), 2013-2020 ($MN)
Table 32 Global Nuclear Medicine Market Analysis, by Thorium-227 (Th-227), 2013-2020 ($MN)
Table 33 Global Nuclear Medicine Market Analysis, by Brachytherapy, 2013-2020 ($MN)
Table 34 Global Nuclear Medicine Market Analysis, by Cesium (Cs-131), 2013-2020 ($MN)
Table 35 Global Nuclear Medicine Market Analysis, by Iodine (I-125), 2013-2020 ($MN)
Table 36 Global Nuclear Medicine Market Analysis, by Iridium (Ir-192), 2013-2020 ($MN)
Table 37 Global Nuclear Medicine Market Analysis, by Palladium (Pd-103), 2013-2020 ($MN)
Table 38 Global Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 39 Global Nuclear Medicine Market Analysis, by End User, 2013-2020 ($MN)
Table 40 Global Nuclear Medicine Market Analysis, by Hospitals, 2013-2020 ($MN)
Table 41 Global Nuclear Medicine Market Analysis, by Diagnostic centers, 2013-2020 ($MN)
Table 42 North America Nuclear Medicine Market Analysis, by Isotope, 2013-2020 ($MN)
Table 43 North America Nuclear Medicine Market Analysis, by Diagnostics, 2013-2020 ($MN)
Table 44 North America Nuclear Medicine Market Analysis, by SPECT, 2013-2020 ($MN)
Table 45 North America Nuclear Medicine Market Analysis, by Iodine (I-123), 2013-2020 ($MN)
Table 46 North America Nuclear Medicine Market Analysis, by Gallium (Ga-67), 2013-2020 ($MN)
Table 47 North America Nuclear Medicine Market Analysis, by Thallium (Tl-201), 2013-2020 ($MN)
Table 48 North America Nuclear Medicine Market Analysis, by Technetium (Tc-99m), 2013-2020 ($MN)
Table 49 North America Nuclear Medicine Market Analysis, by Rhenium (Re-186), 2013-2020 ($MN)
Table 50 North America Nuclear Medicine Market Analysis, by Yttrium (Y-90), 2013-2020 ($MN)
Table 51 North America Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 52 North America Nuclear Medicine Market Analysis, by PET, 2013-2020 ($MN)
Table 53 North America Nuclear Medicine Market Analysis, by Fludeoxyglucose (18f-FDG), 2013-2020 ($MN)
Table 54 North America Nuclear Medicine Market Analysis, by Rubidium (Rb-82), 2013-2020 ($MN)
Table 55 North America Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 56 North America Nuclear Medicine Market Analysis, by Therapy, 2013-2020 ($MN)
Table 57 North America Nuclear Medicine Market Analysis, by Beta radiation therapy, 2013-2020 ($MN)
Table 58 North America Nuclear Medicine Market Analysis, by Erbium (Er-169), 2013-2020 ($MN)
Table 59 North America Nuclear Medicine Market Analysis, by Iodine (I-131), 2013-2020 ($MN)
Table 60 North America Nuclear Medicine Market Analysis, by Lutetium (Lu-177), 2013-2020 ($MN)
Table 61 North America Nuclear Medicine Market Analysis, by Rhenium (Re-186), 2013-2020 ($MN)
Table 62 North America Nuclear Medicine Market Analysis, by Samarium (Sm-153), 2013-2020 ($MN)
Table 63 North America Nuclear Medicine Market Analysis, by Strontium (Sr-89), 2013-2020 ($MN)
Table 64 North America Nuclear Medicine Market Analysis, by Yttrium (Y-90), 2013-2020 ($MN)
Table 65 North America Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 66 North America Nuclear Medicine Market Analysis, by Alpha radiation therapy, 2013-2020 ($MN)
Table 67 North America Nuclear Medicine Market Analysis, by Actinium (Ac-225), 2013-2020 ($MN)
Table 68 North America Nuclear Medicine Market Analysis, by Actinium (Ac-225), 2013-2020 ($MN)
Table 69 North America Nuclear Medicine Market Analysis, by Astatine-211 (At-211), 2013-2020 ($MN)
Table 70 North America Nuclear Medicine Market Analysis, by Lead (Pb-212)/Bismuth (Bi-212), 2013-2020 ($MN)
Table 71 North America Nuclear Medicine Market Analysis, by Radium (Ra-223), 2013-2020 ($MN)
Table 72 North America Nuclear Medicine Market Analysis, by Radium-224 (Ra-224), 2013-2020 ($MN)
Table 73 North America Nuclear Medicine Market Analysis, by Thorium-227 (Th-227), 2013-2020 ($MN)
Table 74 North America Nuclear Medicine Market Analysis, by Brachytherapy, 2013-2020 ($MN)
Table 75 North America Nuclear Medicine Market Analysis, by Cesium (Cs-131), 2013-2020 ($MN)
Table 76 North America Nuclear Medicine Market Analysis, by Iodine (I-125), 2013-2020 ($MN)
Table 77 North America Nuclear Medicine Market Analysis, by Iridium (Ir-192), 2013-2020 ($MN)
Table 78 North America Nuclear Medicine Market Analysis, by Palladium (Pd-103), 2013-2020 ($MN)
Table 79 North America Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 80 North America Nuclear Medicine Market Analysis, by End User, 2013-2020 ($MN)
Table 81 North America Nuclear Medicine Market Analysis, by Hospitals, 2013-2020 ($MN)
Table 82 North America Nuclear Medicine Market Analysis, by Diagnostic centers, 2013-2020 ($MN)
Table 83 Europe Nuclear Medicine Market Analysis, by Isotope, 2013-2020 ($MN)
Table 84 Europe Nuclear Medicine Market Analysis, by Diagnostics, 2013-2020 ($MN)
Table 85 Europe Nuclear Medicine Market Analysis, by SPECT, 2013-2020 ($MN)
Table 86 Europe Nuclear Medicine Market Analysis, by Iodine (I-123), 2013-2020 ($MN)
Table 87 Europe Nuclear Medicine Market Analysis, by Gallium (Ga-67), 2013-2020 ($MN)
Table 88 Europe Nuclear Medicine Market Analysis, by Thallium (Tl-201), 2013-2020 ($MN)
Table 89 Europe Nuclear Medicine Market Analysis, by Technetium (Tc-99m), 2013-2020 ($MN)
Table 90 Europe Nuclear Medicine Market Analysis, by Rhenium (Re-186), 2013-2020 ($MN)
Table 91 Europe Nuclear Medicine Market Analysis, by Yttrium (Y-90), 2013-2020 ($MN)
Table 92 Europe Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 93 Europe Nuclear Medicine Market Analysis, by PET, 2013-2020 ($MN)
Table 94 Europe Nuclear Medicine Market Analysis, by Fludeoxyglucose (18f-FDG), 2013-2020 ($MN)
Table 95 Europe Nuclear Medicine Market Analysis, by Rubidium (Rb-82), 2013-2020 ($MN)
Table 96 Europe Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 97 Europe Nuclear Medicine Market Analysis, by Therapy, 2013-2020 ($MN)
Table 98 Europe Nuclear Medicine Market Analysis, by Beta radiation therapy, 2013-2020 ($MN)
Table 99 Europe Nuclear Medicine Market Analysis, by Erbium (Er-169), 2013-2020 ($MN)
Table 100 Europe Nuclear Medicine Market Analysis, by Iodine (I-131), 2013-2020 ($MN)
Table 101 Europe Nuclear Medicine Market Analysis, by Lutetium (Lu-177), 2013-2020 ($MN)
Table 102 Europe Nuclear Medicine Market Analysis, by Rhenium (Re-186), 2013-2020 ($MN)
Table 103 Europe Nuclear Medicine Market Analysis, by Samarium (Sm-153), 2013-2020 ($MN)
Table 104 Europe Nuclear Medicine Market Analysis, by Strontium (Sr-89), 2013-2020 ($MN)
Table 105 Europe Nuclear Medicine Market Analysis, by Yttrium (Y-90), 2013-2020 ($MN)
Table 106 Europe Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 107 Europe Nuclear Medicine Market Analysis, by Alpha radiation therapy, 2013-2020 ($MN)
Table 108 Europe Nuclear Medicine Market Analysis, by Actinium (Ac-225), 2013-2020 ($MN)
Table 109 Europe Nuclear Medicine Market Analysis, by Actinium (Ac-225), 2013-2020 ($MN)
Table 110 Europe Nuclear Medicine Market Analysis, by Astatine-211 (At-211), 2013-2020 ($MN)
Table 111 Europe Nuclear Medicine Market Analysis, by Lead (Pb-212)/Bismuth (Bi-212), 2013-2020 ($MN)
Table 112 Europe Nuclear Medicine Market Analysis, by Radium (Ra-223), 2013-2020 ($MN)
Table 113 Europe Nuclear Medicine Market Analysis, by Radium-224 (Ra-224), 2013-2020 ($MN)
Table 114 Europe Nuclear Medicine Market Analysis, by Thorium-227 (Th-227), 2013-2020 ($MN)
Table 115 Europe Nuclear Medicine Market Analysis, by Brachytherapy, 2013-2020 ($MN)
Table 116 Europe Nuclear Medicine Market Analysis, by Cesium (Cs-131), 2013-2020 ($MN)
Table 117 Europe Nuclear Medicine Market Analysis, by Iodine (I-125), 2013-2020 ($MN)
Table 118 Europe Nuclear Medicine Market Analysis, by Iridium (Ir-192), 2013-2020 ($MN)
Table 119 Europe Nuclear Medicine Market Analysis, by Palladium (Pd-103), 2013-2020 ($MN)
Table 120 Europe Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 121 Europe Nuclear Medicine Market Analysis, by End User, 2013-2020 ($MN)
Table 122 Europe Nuclear Medicine Market Analysis, by Hospitals, 2013-2020 ($MN)
Table 123 Europe Nuclear Medicine Market Analysis, by Diagnostic centers, 2013-2020 ($MN)
Table 124 Asia Pacific Nuclear Medicine Market Analysis, by Isotope, 2013-2020 ($MN)
Table 125 Asia Pacific Nuclear Medicine Market Analysis, by Diagnostics, 2013-2020 ($MN)
Table 126 Asia Pacific Nuclear Medicine Market Analysis, by SPECT, 2013-2020 ($MN)
Table 127 Asia Pacific Nuclear Medicine Market Analysis, by Iodine (I-123), 2013-2020 ($MN)
Table 128 Asia Pacific Nuclear Medicine Market Analysis, by Gallium (Ga-67), 2013-2020 ($MN)
Table 129 Asia Pacific Nuclear Medicine Market Analysis, by Thallium (Tl-201), 2013-2020 ($MN)
Table 130 Asia Pacific Nuclear Medicine Market Analysis, by Technetium (Tc-99m), 2013-2020 ($MN)
Table 131 Asia Pacific Nuclear Medicine Market Analysis, by Rhenium (Re-186), 2013-2020 ($MN)
Table 132 Asia Pacific Nuclear Medicine Market Analysis, by Yttrium (Y-90), 2013-2020 ($MN)
Table 133 Asia Pacific Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 134 Asia Pacific Nuclear Medicine Market Analysis, by PET, 2013-2020 ($MN)
Table 135 Asia Pacific Nuclear Medicine Market Analysis, by Fludeoxyglucose (18f-FDG), 2013-2020 ($MN)
Table 136 Asia Pacific Nuclear Medicine Market Analysis, by Rubidium (Rb-82), 2013-2020 ($MN)
Table 137 Asia Pacific Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 138 Asia Pacific Nuclear Medicine Market Analysis, by Therapy, 2013-2020 ($MN)
Table 139 Asia Pacific Nuclear Medicine Market Analysis, by Beta radiation therapy, 2013-2020 ($MN)
Table 140 Asia Pacific Nuclear Medicine Market Analysis, by Erbium (Er-169), 2013-2020 ($MN)
Table 141 Asia Pacific Nuclear Medicine Market Analysis, by Iodine (I-131), 2013-2020 ($MN)
Table 142 Asia Pacific Nuclear Medicine Market Analysis, by Lutetium (Lu-177), 2013-2020 ($MN)
Table 143 Asia Pacific Nuclear Medicine Market Analysis, by Rhenium (Re-186), 2013-2020 ($MN)
Table 144 Asia Pacific Nuclear Medicine Market Analysis, by Samarium (Sm-153), 2013-2020 ($MN)
Table 145 Asia Pacific Nuclear Medicine Market Analysis, by Strontium (Sr-89), 2013-2020 ($MN)
Table 146 Asia Pacific Nuclear Medicine Market Analysis, by Yttrium (Y-90), 2013-2020 ($MN)
Table 147 Asia Pacific Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 148 Asia Pacific Nuclear Medicine Market Analysis, by Alpha radiation therapy, 2013-2020 ($MN)
Table 149 Asia Pacific Nuclear Medicine Market Analysis, by Actinium (Ac-225), 2013-2020 ($MN)
Table 150 Asia Pacific Nuclear Medicine Market Analysis, by Actinium (Ac-225), 2013-2020 ($MN)
Table 151 Asia Pacific Nuclear Medicine Market Analysis, by Astatine-211 (At-211), 2013-2020 ($MN)
Table 152 Asia Pacific Nuclear Medicine Market Analysis, by Lead (Pb-212)/Bismuth (Bi-212), 2013-2020 ($MN)
Table 153 Asia Pacific Nuclear Medicine Market Analysis, by Radium (Ra-223), 2013-2020 ($MN)
Table 154 Asia Pacific Nuclear Medicine Market Analysis, by Radium-224 (Ra-224), 2013-2020 ($MN)
Table 155 Asia Pacific Nuclear Medicine Market Analysis, by Thorium-227 (Th-227), 2013-2020 ($MN)
Table 156 Asia Pacific Nuclear Medicine Market Analysis, by Brachytherapy, 2013-2020 ($MN)
Table 157 Asia Pacific Nuclear Medicine Market Analysis, by Cesium (Cs-131), 2013-2020 ($MN)
Table 158 Asia Pacific Nuclear Medicine Market Analysis, by Iodine (I-125), 2013-2020 ($MN)
Table 159 Asia Pacific Nuclear Medicine Market Analysis, by Iridium (Ir-192), 2013-2020 ($MN)
Table 160 Asia Pacific Nuclear Medicine Market Analysis, by Palladium (Pd-103), 2013-2020 ($MN)
Table 161 Asia Pacific Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 162 Asia Pacific Nuclear Medicine Market Analysis, by End User, 2013-2020 ($MN)
Table 163 Asia Pacific Nuclear Medicine Market Analysis, by Hospitals, 2013-2020 ($MN)
Table 164 Asia Pacific Nuclear Medicine Market Analysis, by Diagnostic centers, 2013-2020 ($MN)
Table 165 RoW Nuclear Medicine Market Analysis, by Isotope, 2013-2020 ($MN)
Table 166 RoW Nuclear Medicine Market Analysis, by Diagnostics, 2013-2020 ($MN)
Table 167 RoW Nuclear Medicine Market Analysis, by SPECT, 2013-2020 ($MN)
Table 168 RoW Nuclear Medicine Market Analysis, by Iodine (I-123), 2013-2020 ($MN)
Table 169 RoW Nuclear Medicine Market Analysis, by Gallium (Ga-67), 2013-2020 ($MN)
Table 170 RoW Nuclear Medicine Market Analysis, by Thallium (Tl-201), 2013-2020 ($MN)
Table 171 RoW Nuclear Medicine Market Analysis, by Technetium (Tc-99m), 2013-2020 ($MN)
Table 172 RoW Nuclear Medicine Market Analysis, by Rhenium (Re-186), 2013-2020 ($MN)
Table 173 RoW Nuclear Medicine Market Analysis, by Yttrium (Y-90), 2013-2020 ($MN)
Table 174 RoW Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 175 RoW Nuclear Medicine Market Analysis, by PET, 2013-2020 ($MN)
Table 176 RoW Nuclear Medicine Market Analysis, by Fludeoxyglucose (18f-FDG), 2013-2020 ($MN)
Table 177 RoW Nuclear Medicine Market Analysis, by Rubidium (Rb-82), 2013-2020 ($MN)
Table 178 RoW Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 179 RoW Nuclear Medicine Market Analysis, by Therapy, 2013-2020 ($MN)
Table 180 RoW Nuclear Medicine Market Analysis, by Beta radiation therapy, 2013-2020 ($MN)
Table 181 RoW Nuclear Medicine Market Analysis, by Erbium (Er-169), 2013-2020 ($MN)
Table 182 RoW Nuclear Medicine Market Analysis, by Iodine (I-131), 2013-2020 ($MN)
Table 183 RoW Nuclear Medicine Market Analysis, by Lutetium (Lu-177), 2013-2020 ($MN)
Table 184 RoW Nuclear Medicine Market Analysis, by Rhenium (Re-186), 2013-2020 ($MN)
Table 185 RoW Nuclear Medicine Market Analysis, by Samarium (Sm-153), 2013-2020 ($MN)
Table 186 RoW Nuclear Medicine Market Analysis, by Strontium (Sr-89), 2013-2020 ($MN)
Table 187 RoW Nuclear Medicine Market Analysis, by Yttrium (Y-90), 2013-2020 ($MN)
Table 188 RoW Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 189 RoW Nuclear Medicine Market Analysis, by Alpha radiation therapy, 2013-2020 ($MN)
Table 190 RoW Nuclear Medicine Market Analysis, by Actinium (Ac-225), 2013-2020 ($MN)
Table 191 RoW Nuclear Medicine Market Analysis, by Actinium (Ac-225), 2013-2020 ($MN)
Table 192 RoW Nuclear Medicine Market Analysis, by Astatine-211 (At-211), 2013-2020 ($MN)
Table 193 RoW Nuclear Medicine Market Analysis, by Lead (Pb-212)/Bismuth (Bi-212), 2013-2020 ($MN)
Table 194 RoW Nuclear Medicine Market Analysis, by Radium (Ra-223), 2013-2020 ($MN)
Table 195 RoW Nuclear Medicine Market Analysis, by Radium-224 (Ra-224), 2013-2020 ($MN)
Table 196 RoW Nuclear Medicine Market Analysis, by Thorium-227 (Th-227), 2013-2020 ($MN)
Table 197 RoW Nuclear Medicine Market Analysis, by Brachytherapy, 2013-2020 ($MN)
Table 198 RoW Nuclear Medicine Market Analysis, by Cesium (Cs-131), 2013-2020 ($MN)
Table 199 RoW Nuclear Medicine Market Analysis, by Iodine (I-125), 2013-2020 ($MN)
Table 200 RoW Nuclear Medicine Market Analysis, by Iridium (Ir-192), 2013-2020 ($MN)
Table 201 RoW Nuclear Medicine Market Analysis, by Palladium (Pd-103), 2013-2020 ($MN)
Table 202 RoW Nuclear Medicine Market Analysis, by Others, 2013-2020 ($MN)
Table 203 RoW Nuclear Medicine Market Analysis, by End User, 2013-2020 ($MN)
Table 204 RoW Nuclear Medicine Market Analysis, by Hospitals, 2013-2020 ($MN)
Table 205 RoW Nuclear Medicine Market Analysis, by Diagnostic centers, 2013-2020 ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Global Nuclear Medicine Market

Global Nuclear Medicine Market

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global nuclear medicines market is expected to reach USD 17,600 million by the end of 2020, growing at a CAGR of around 12.29% from 2015 to 2020. Nuclear medicine utilizes the radioisotope for application ...

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global European ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.